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Introduction {#sec1}
============

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated coronavirus disease 2019 (COVID-19) emerged in China in December 2019 and has spread globally, creating a worldwide pandemic and a public health crisis of historic dimensions \[[@bib1]\]. The clinical spectrum of COVID-19 varies widely, from asymptomatic disease to pneumonia and life-threatening complications, including acute respiratory distress syndrome (ARDS), multisystem organ failure and ultimately death \[[@bib2], [@bib3], [@bib4]\].

Several case series or cohorts describing the clinical characteristics and outcomes of patients with severe COVID-19 have been reported summarizing the experience of city or regional hospitals in China \[[@bib2],[@bib5],[@bib6]\], Singapore \[[@bib7]\] and New York City \[[@bib8],[@bib9]\], as well as case series of critically ill patients admitted to intensive care units (ICUs) in China \[[@bib10]\], Italy \[[@bib4]\] and the United States \[[@bib11]\]. However, variations in the rates for COVID-19 hospitalizations and deaths may occur across different areas even in the same country, suggesting differences in population characteristics or inequities in the access to care \[[@bib12]\]. We are aware of three prior published nationwide cohorts of hospitalized patients with COVID-19, two from China \[[@bib3],[@bib13]\] and one from the United Kingdom \[[@bib14]\]. None of these three cohorts explored both clinical and laboratory variables associated with hospital death.

Our study aimed to determine the epidemiologic and clinical characteristics of hospitalized patients with COVID-19 in Spain, and to identify clinical and laboratory predictors of death.

Patients and methods {#sec2}
====================

Design and patient selection {#sec2.1}
----------------------------

COVID-19\@Spain is a retrospective nationwide cohort study of patients admitted to Spanish hospitals with laboratory-confirmed COVID-19 infection by real-time PCR (RT-PCR) assay for SARS-CoV-2. Investigators from participating centres were asked to include the first consecutive hospitalized patients (up to 100) meeting the study criteria from the start of the epidemic in Spain until 17 March 2020. The Ethics Committee for Research with Medicines of Hospital General Universitario Gregorio Marañón approved the study and waived informed consent for the collection of clinical data.

Investigations {#sec2.2}
--------------

The data source comprised the electronic medical records. All data were collected using an electronic case report form (eCRF), a modified version of the World Health Organization International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC) Core CRF \[[@bib15]\]. The eCRF was built using REDCap electronic data capture tools \[[@bib16]\] and was hosted at SEIMC (Spanish Society of Infectious Diseases and Clinical Microbiology)/GESIDA (AIDS Study Group) Foundation (FSG).

The variables registered included administrative data, epidemiologic information and type of clinical specimen in which the diagnosis was confirmed. We also registered demographics, comorbidities, current medications, signs and symptoms at admission, baseline laboratory tests results, chest radiographic findings at baseline and during follow-up, development of ARDS and other complications during hospitalization, use of medications with purported activity against COVID-19, use of adjunctive medications to modulate the host inflammatory response, admission to a high-dependency unit or ICU, noninvasive ventilation, mechanical ventilation, use of extracorporeal membrane oxygenation, vasopressor agents and renal replacement therapy.

The clinical status of the patients as of 17 April 2020 was categorized as discharged alive (with date of discharge), alive and currently hospitalized or dead (with date of death). For patients who were discharged and subsequently readmitted during the study period, only one hospital admission episode was considered for purposes of analysis.

Outcome {#sec2.3}
-------

The primary endpoint was all-cause mortality. Baseline was the date of hospital admission. The follow-up censoring date was 17 April 2020.

Definitions {#sec2.4}
-----------

Comorbidities and complications during hospitalization were defined as diagnoses included in the medical record. Cancer was defined as the presence of an active solid or haematologic malignant neoplasm. Obesity was defined as a body mass index of \>30 kg/m^2^. ARDS was defined as the acute onset or worsening of respiratory symptoms with severe hypoxaemia and bilateral opacities on chest radiograph not fully explained by cardiac failure or fluid overload \[[@bib17]\].

Study oversight {#sec2.5}
---------------

The investigators of each participating centre vouch for the completeness and accuracy of the data. FSG monitors maintained close contact with investigators for problem resolution during the period of data retrieval; they checked the database for missing, invalid and inconsistent data; and they managed queries before the analysis.

Statistical analysis {#sec2.6}
--------------------

Univariable and multivariable Cox regression analyses were performed to identify factors associated with death. To obtain a reduced set of variables from the broad set of predictors, we carried out a blockwise forward procedure allocating the predictor variables into five clusters: sociodemographic characteristics, comorbidities, admission signs and symptoms, vital signs and laboratory parameters. A multivariable regression analysis was fitted within each block using two criteria to achieve the best set of predictors: relevance to the clinical situation and statistical significance (p \< 0.10). We used variance inflation factors to detect collinearity among predictors included in the multivariable models. We carried out a sensitivity analysis in which the order of entry of the blocks was inverted. We checked the proportional hazards assumption. Variables with more than 25% missing values have not been considered, and missing values were treated as a separate category for analysis. Heterogeneity introduced by different hospitals was accounted for by using robust methods to estimate standard errors, and thus to calculate 95% confidence intervals and p values.

Statistical analyses were performed by Stata 15.0 software (StataCorp, College Station, TX, USA). This study was registered with [ClinicalTrials.gov](http://ClinicalTrials.gov){#intref0010} as trial [NCT04355871](NCT04355871){#intref0015}. The STROBE guidelines were used to ensure the reporting of the study ([Supplementary Table S1](#appsec2){ref-type="sec"}).

Results {#sec3}
=======

The final cohort included 4035 hospitalized patients ([Supplementary Fig. S1](#appsec2){ref-type="sec"}) in whom SARS-CoV-2 was detected by RT-PCR by testing nasopharyngeal swabs (89.6%), pharyngeal swabs (13.4%), low respiratory tract specimens (1.3%) and other specimens (4.4%). The median admission date was 13 March 2020, with little variability among the median admission date between the centres (range from 6 to 17 March). The median follow-up time was 34 days (interquartile range (IQR), 24--37 days). A total of 141 patients (3.6%) were discharged and readmitted during the study period, a median time of 5 days (IQR, 2--9 days) after discharge.

Demographics and presenting clinical features {#sec3.1}
---------------------------------------------

Patient characteristics, categorized by survival, are shown in [Table 1](#tbl1){ref-type="table"} . In brief, male subjects accounted for 61.0%, the median age was 70 years and 25.1% were ≥80 years old. Most patients were Spanish-born whites. The age distribution of patients stratified by sex is shown in [Fig. 1](#fig1){ref-type="fig"} (A).Table 1Demographics, comorbidity data and current medications of 4035 hospitalized patients with COVID-19 stratified according to vital status at study censoring dateTable 1CharacteristicAlive (*n* = 2904)Dead (*n* = 1131)pTotal (*N* = 4035)Sex\<0.001 Male1666/2868 (58.1)767/1119 (68.5)2433/3987 (61.0) Female1202/2868 (41.9)352/1119 (31.5)1554/3987 (39.0)Pregnant female13/1136 (1.1)2/329 (0.6)0.39515/1465 (1.0) Gestational week, median (IQR)33 (17--38)---33 (17--38)Age Median (IQR) (years)65 (51--75)79 (71--86)\<0.00170 (56--80) Distribution\<0.001 0--10 years13/2901 (0.4)2/1130 (0.2)15/4031 (0.4) 11--20 years18/2901 (0.6)0/1130 (0)18/4031 (0.5) 21--30 years89/2901 (3.1)2/1130 (0.2)91/4031 (2.3) 31--40 years210/2901 (7.2)5/1130 (0.4)215/4031 (5.3) 41--50 years373/2901 (12.9)18/1130 (1.6)391/4031 (9.7) 51--60 years483/2901 (16.6)68/1130 (6.0)551/4031 (13.7) 61--70 years624/2901 (21.5)167/1130 (14.8)791/4031 (19.6) 71--80 years675/2901 (23.3)357/1130 (31.6)1032/4031 (25.6) 81--90 years355/2901 (12.2)389/1130 (34.4)744/4031 (18.5) ≥91 years61/2901 (2.1)122/1130 (10.8)183/4031 (4.5)Country of birth\<0.001 Spain2505/2819 (88.9)1065/1101 (96.7)3570/3920 (91.1) Other314/2819 (11.1)36/1101 (3.3)350/3920 (8.9)Ethnic group\<0.001 Arab21/2821 (0.7)3/1094 (0.3)24/3915 (0.6) Asian16/2821 (0.6)2/1094 (0.2)18/3915 (0.5) Black12/2821 (0.4)012/3915 (0.3) Latin American166/2821 (5.9)20/1094 (1.8)186/3915 (4.7) White2578/2821 (91.4)1064/1094 (97.3)3642/3915 (93.0) Other28/2821 (1.0)5/1094 (0.5)33/3915 (0.8)Comorbidity Smoking history\<0.001 Current smoker134/2123 (6.3)63/794 (7.9)197/2917 (6.7) Former smoker613/2123 (28.9)334/794 (42.1)947/2917 (32.5) Never smoked1376/2123 (64.8)397/794 (50.0)1773/2917 (60.8) Comorbid conditions\<0.001 0848/2501 (33.9)52/938 (5.5)900/3439 (26.2) 1--21172/2501 (46.9)448/938 (47.8)1620/3439 (47.1) ≥3481/2501 (19.2)438/938 (46.7)919/3439 (26.7) Types of comorbid conditions Hypertension1251/2885 (43.4)801/1125 (71.2)\<0.0012052/4010 (51.2) Chronic heart disease488/2875 (17.0)444/1119 (39.7)\<0.001932/3994 (23.3) Diabetes514/2884 (17.8)357/1118 (31.9)\<0.001871/4002 (21.8) Chronic pulmonary disease (not asthma)405/2879 (14.1)310/1116 (27.8)\<0.001715/3995 (17.9) Obesity316/2618 (12.1)181/988 (18.3)\<0.001497/3606 (13.8) Chronic neurologic disorder203/2886 (7.0)170/1116 (15.2)\<0.001373/4002 (9.3) Dementia124/2871 (4.3)191/1108 (17.2)\<0.001315/3979 (7.9) Asthma230/2884 (8.0)69/1116 (6.2)0.053299/4000 (7.5) Solid neoplasm (active)146/2882 (5.1)121/1116 (10.8)\<0.001267/3998 (6.7) Inflammatory disease148/2883 (5.1)83/1114 (7.4)0.005231/3997 (5.8) Chronic kidney disease stage 4 (eGFR \<30 mL/min/1.73 m^2^)87/2882 (3.0)112/1118 (10.0)\<0.001199/4000 (5.0) Haematologic neoplasm (active)45/2885 (1.6)47/1120 (4.2)\<0.00192/4005 (2.3) Liver cirrhosis28/2882 (1.0)26/1116 (2.3)0.00154/3998 (1.3) HIV/AIDS20/2860 (0.7)6/1102 (0.5)0.58926/3962 (0.7) Current medications Angiotensin-converting enzyme inhibitors489/2878 (17.0)283/1105 (25.6)\<0.001772/3983 (19.4) Angiotensin II receptor blockers434/2879 (15.1)254/1108 (22.9)\<0.001688/3987 (17.3) Corticosteroids, inhaled303/2875 (10.5)184/1110 (16.6)\<0.001487/3985 (12.2) Corticosteroids, systemic113/2872 (3.9)95/1110 (8.6)\<0.001208/3982 (5.2) Antineoplastic agents59/2875 (2.0)49/1110 (4.4)\<0.001108/3985 (2.7) Biologic anti-inflammatory drugs69/2871 (2.4)27/1106 (2.4)0.94496/3977 (2.4) Antiretroviral drugs15/19 (78.9)6/6 (100.0)0.22021/25 (84.0)[^3][^4]Fig. 1(A) Distribution of hospitalized patients with coronavirus disease 2019 (COVID-19) stratified by age and sex. (B) Mortality of patients with COVID-19 stratified by age and sex.Fig. 1

At least one comorbidity was present in 73.8%, and 26.7% had at least three comorbid conditions. The most common comorbidities were arterial hypertension (51.2%), chronic heart disease (23.3%), diabetes mellitus (21.8%), chronic pulmonary disease (not asthma) (17.9%) and obesity (13.8%). Only 0.7% patients had HIV. Before admission, 19.4% patients had been provided angiotensin-converting enzyme (ACE) inhibitors and 17.3% were receiving angiotensin II receptor blockers ([Table 1](#tbl1){ref-type="table"}).

The median duration of symptoms before hospitalization was 4 days (IQR, 2--7 days), and the most commonly reported symptoms were history of fever (81.0%), cough (71.8%), malaise (64.0%), dyspnoea (49.1%), upper respiratory tract symptoms (30.8%), myalgia or arthralgia (24.9%) and sputum production (24.1%) ([Supplementary Table S2](#appsec2){ref-type="sec"}). Abnormal vital signs at admission included fever (40.9%), arterial hypotension (18.8%) and marked tachypnoea (10.9%). Low age-adjusted arterial oxygen saturation (SaO~2~) levels on room air were reported in 26.6% patients ([Supplementary Table S3](#appsec2){ref-type="sec"}).

Chest radiograph findings {#sec3.2}
-------------------------

Infiltrates on initial chest radiograph were observed in 77.6% patients, of whom 71.3% had bilateral involvement. Over the whole hospital course, worsening of the baseline infiltrates was observed in 64.7% patients, with new lesions in 51.0%.

Laboratory findings {#sec3.3}
-------------------

Baseline laboratory findings are shown in [Table 2](#tbl2){ref-type="table"} . The most common abnormalities in blood counts included lymphopenia (54.2%) and thrombocytopenia (31.5%). The median neutrophil-to-lymphocyte ratio was 4.5. A prolonged activated partial thromboplastin time was present in 9.4%, and 57.1% had D-dimer levels above the normal range. High serum levels were reported from alanine aminotransferase (25.3%), aspartate aminotransferase (34.7%), lactate dehydrogenase (64.5%), creatine kinase (23.5%), C-reactive protein (91.9%) and procalcitonin (14.2%). Low serum albumin was found in 36.0% patients, and 6.8% had an estimated glomerular filtration rate of \<30 mL/min/1.73 m^2^ by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. Ferritin and interleukin 6 were determined in a limited number of patients, and high concentrations of these parameters were found in 75.1% and 90.0% respectively.Table 2Laboratory findings of 4035 hospitalized patients with COVID-19 stratified according to vital status at study censoring dateTable 2Laboratory parameterAlive (*n* = 2904)Death (*n* = 1131)pTotal (*N* = 4035)Haemoglobin No. of patients with data286011203980 Median (IQR) (g/L)13.8 (12.6--14.9)12.9 (11.5--14.4)\<0.00113.6 (12.3--14.8)Haematocrit No. of patients with data283211053937 Median (IQR) (%)41.0 (37.9--44.0)39.1 (34.8--43.0)\<0.00140.6 (37.0--44.0)WBC count Median (IQR) (×10^9^/L)5635 (4330--7420)6900 (5000--9470)\<0.0015910 (4490--7990) Distribution\<0.001 \>12 000 × 10^9^/L152/2854 (5.3)160/1117 (14.3)312/3971 (7.9) \<4000 × 10^9^/L529/2854 (18.5)137/1117 (12.3)666/3971 (16.8)Neutrophil count Median (IQR) (/μL)3920 (2800--5560)5300 (3530--7700)\<0.0014200 (2920--6120) \<1000/μL51/2848 (1.8)24/1113 (2.2)0.44875/3961 (1.9)Lymphocyte count Median (IQR) (/μL)1000 (700--1360)780 (540--1160)\<0.001900 (640--1300) \<1000/μL1423/2852 (49.9)727/1111 (65.4)\<0.0012150/3963 (54.2)Neutrophil-to-lymphocyte ratio Median (IQR)3.9 (2.5--6.5)6.6 (3.7--11.4)\<0.0014.5 (2.7--7.7) Distribution Tertile 11094/2839 (38.5)222/1106 (20.1)\<0.0011316/3945 (33.4) Tertile 21005/2839 (35.4)309/1106 (27.9)1314/3945 (33.3) Tertile 3740/2839 (26.1)575/1106 (52.0)1315/3945 (33.3)Platelets Median (IQR) (×10^9^/L)181 000 (143 000--229 000)168 000 (130 000--221 000)\<0.001178 000 (139 000--226 000) Platelets \<150 000 × 10^9^/L831/2842 (29.2)416/1118 (37.2)\<0.0011247/3960 (31.5)Prolonged APTT (\>39.2 seconds or ratio \>1.25)161/2232 (7.2)133/880 (15.1)\<0.001294/3112 (9.4)INR Median (IQR)1.1 (1.0--1.2)1.2 (1.1--1.3)\<0.0011.1 (1.0--1.2) INR \> 1.1954/2376 (40.1)549/925 (59.3)\<0.0011503/3301 (45.5)D-dimer Median (IQR) (ng/mL)548 (328--934)740 (410--1590)\<0.001580 (339--1040) High D-dimer levels (\>500 ng/mL)639/1184 (54.0)253/379 (66.7)\<0.001892/1563 (57.1)Glucose No. of patients with data276610843850 Median (IQR) (mg/dL)106 (93--126)125 (104--165)\<0.001110 (95--136)Creatinine No. of patients with data283211113943 Median (IQR)0.88 (0.72--1.07)1.10 (0.84--1.46)\<0.0010.92 (0.74--1.18)eGFR (mL/min/1.73 m^2^) (CKD-EPI) Median (IQR)84.1 (65.3--97.4)60.2 (40.1--80.4)\<0.00178.4 (56.5--93.6) Distribution\<0.001 \>60 mL/min/1.73 m^2^2234/2797 (79.9)552/1098 (50.3)2786/3895 (71.5) 30--59 mL/min/1.73 m^2^456/2797 (16.3)388/1098 (35.3)844/3895 (21.7) \<30 mL/min/1.73 m^2^107/2797 (3.8)158/1098 (14.4)265/3895 (6.8)Sodium No. of patients with data282511093934 Median (IQR) (mEq/L)138 (135--140)137 (135--140)0.008138 (135--140)Potassium No. of patients with data277010703840 Median (IQR) (mEq/L)4.1 (3.8--4.4)4.2 (3.8--4.6)\<0.0014.1 (3.8--4.4)ALT Median (IQR) (U/L)27 (18--42)25 (17--38)0.00326 (18--41) High serum levels ≥40 U/L and ≤200 U/L630/2369 (26.6)190/870 (21.8)0.021820/3239 (25.3) High serum levels \>200 U/L23/2369 (1.0)8/870 (0.9)31/3239 (1.0)AST Median (IQR) (U/L)31 (23--45)34 (23--52)0.03332 (23--48) High serum levels ≥ 40 U/L and ≤200 U/L680/2051 (33.1)291/750 (38.8)0.011971/2801 (34.7) High serum levels \>200 U/L17/2051 (0.8)9/750 (1.2)26/2801 (0.9)AST/ALT ratio\<0.001 \<1675/2013 (33.5)166/733 (22.6)841/2746 (30.6) ≥11338/2013 (66.5)567/733 (77.4)1905/2746 (69.4)Total bilirubin No. of patients with data19207302650 Median (IQR) (mg/dL)0.50 (0.37--0.71)0.56 (0.39--0.87)\<0.0010.50 (0.37--0.80)Serum albumin Median (IQR) (g/dL)3.6 (3.2--4.0)3.4 (3.0--3.8)\<0.0013.5 (3.2--3.9) Low albumin levels (\<3.4 g/dL)310/991 (31.3)198/420 (47.1)\<0.001508/1411 (36.0)Lactate dehydrogenase Median (IQR) (U/L)281 (215--382)318 (250--463)\<0.001290 (224--403) High lactate dehydrogenase (\>250 U/L)1154/1895 (60.9)510/683 (74.7)\<0.0011664/2578 (64.5)CRP Median (IQR) (mg/L)44 (16--95)87 (38--168)\<0.00154 (20--116) High CRP levels (\>5 mg/L)2388/2654 (90.0)990/1023 (96.8)\<0.0013378/3677 (91.9)Procalcitonin Median (IQR) (μg/L)0.09 (0.05--0.16)0.22 (0.10--0.56)\<0.0010.11 (0.06--0.25) High procalcitonin levels (\>0.50 μg/L)105/1135 (9.2)119/439 (27.1)\<0.001224/1574 (14.2)Creatine kinase Median (IQR) (U/L)90 (56--169)101 (56--217)0.04892 (56--182) High creatine kinase levels (\>190 U/L)184/882 (20.9)102/336 (30.4)\<0.001286/1218 (23.5)Ferritin Median (IQR) (μg/L)611 (278--1238)792 (400--1670)0.002649 (301--1363) High ferritin levels (\>300 μg/L)315/433 (72.7)125/153 (81.7)0.028440/586 (75.1)Interleukin 6 Median (IQR) (pg/mL)33 (13--77)117 (40--512)42 (16--105) High interleukin levels (\>4.3 pg/mL)175/201 (87.1)58/58 (100.0)0.004233/259 (90.0)[^5][^6]

Supportive therapy and medications {#sec3.4}
----------------------------------

High-dependency unit or ICU admission was required for 18.5% patients, 15.5% underwent mechanical ventilation, 11.9% received vasopressors and 3.0% received renal-replacement therapy ([Supplementary Table S4](#appsec2){ref-type="sec"}). Virus-targeted agents were administered to 82.0% patients: lopinavir/ritonavir to 70.4%, hydroxychloroquine to 65.5% and subcutaneous interferon beta to 29.2%, usually in combination with lopinavir/ritonavir. Host-targeted agents included systemic corticosteroids in 28.0% and tocilizumab in 9.4%. Antibiotics other than azithromycin were administered to 80.9% and antifungals to 3.2% ([Supplementary Table S5](#appsec2){ref-type="sec"}).

Complications and mortality {#sec3.5}
---------------------------

The full list of complications during the hospital course is provided in [Supplementary Table S6](#appsec2){ref-type="sec"}. The most common were ARDS (31.5%), acute kidney injury (15.4%), presumed bacterial pneumonia (10.6%), heart failure (5.8%) and bloodstream infection (4.9%). During the study period, 28.0% patients died, 64.1% were discharged and 7.8% remained hospitalized. The median (IQR) time to death since the beginning of symptoms and since hospital admission was 13 (9--19) days and 10 (6--16) days, respectively. Death was particularly high among patients aged ≥80 years (54.9%) ([Fig. 1](#fig1){ref-type="fig"}(B)) and those with three or more comorbid conditions (47.7%). Death was also very high among those with ARDS (59.3%), those who were admitted to the ICU (42.4%) and those who underwent mechanical ventilation (45.7%). The median (IQR) length of stay was 4 (1--9) days for patients who were discharged and 35 (32--38) days for those who remained hospitalized at the censoring date.

Predictors of death {#sec3.6}
-------------------

Independent predictors of death in the different clusters of variables are shown in [Table 3](#tbl3){ref-type="table"} . In the final adjusted analysis, we found 17 factors independently associated with an increased hazard of death: male sex, older age, arterial hypertension, obesity, liver cirrhosis, chronic neurologic disorder, active cancer, dementia, dyspnoea, confusion, low age-adjusted SaO2 on room air, higher white cell blood count, higher neutrophil-to-lymphocyte ratio, lower platelet count, prolonged international normalized ratio, lower estimated glomerular filtration rate and higher concentrations of C-reactive protein ([Fig. 2](#fig2){ref-type="fig"} ). No collinearity was detected, the proportional hazards assumption was fulfilled and the results were not changed when the order of entry of the blocks was inverted. Kaplan-Meier plots for death according to age and sex are shown in [Fig. 3](#fig3){ref-type="fig"} . The adjusted hazard ratio of death for being admitted early in the epidemic (before 13 March) versus later was 1.07 (95% confidence interval, 0.90--1.28; p 0.407). The variable unilateral or bilateral lung opacities had missing values in 29% individuals and was not included in the final model. However, when this variable was included in the model, the adjusted hazard ratio of death for bilateral opacities compared to unilateral opacities was 1.32 (95% confidence interval, 0.11--1.55; p 0.002). We also carried out two *post hoc* analyses (data not shown). In the first one, the predictors of mortality among patients aged ≤65 years were not substantially different from those found in the whole dataset. In the second analysis, the mortality hazard did not change depending on the seroprevalence of IgG anti--SARS-CoV-2 at the provincial level, according to a recent nationwide study in Spain \[[@bib18]\].Table 3Independent predictors of death in different clusters of variablesTable 3CharacteristicHR (95% CI)p**Sociodemographic characteristics**Male sex1.52 (1.33--1.73)\<0.001Age (ref. 0--49 years) 50--65 years3.76 (2.43--5.83)\<0.001 66--79 years8.87 (5.85--13.43)\<0.001 80+ years20.75 (13.72--31.37)\<0.001Comorbidities Hypertension1.81 (1.56--2.09)\<0.001 Chronic heart disease1.58 (1.38--1.81)\<0.001 Diabetes1.23 (1.07--1.41)0.003 Chronic pulmonary disease (not asthma)1.40 (1.21--1.61)\<0.001 Obesity1.21 (1.01--1.44)0.036 Chronic kidney disease stage 4 (eGFR \<30 mL/min/1.73 m^2^)1.55 (1.26--1.91)\<0.001 Liver cirrhosis1.59 (1.03--2.43)0.034 Chronic neurologic disorder1.30 (1.08--1.57)0.006 Cancer1.59 (1.33--1.90)\<0.001 Dementia2.28 (1.90--2.73)\<0.001Admission signs and symptoms Headache0.50 (0.37--0.68)\<0.001 Myalgia/arthralgia0.70 (0.59--0.84)\<0.001 Anosmia0.50 (0.22--1.14)0.099 Cough0.70 (0.60--0.80)\<0.001 Sputum production1.26 (1.09--1.47)0.002 Dyspnea1.93 (1.69--2.19)\<0.001 Chest pain0.64 (0.51--0.81)\<0.001 Vomiting/nausea0.77 (0.62--0.95)0.016 Altered consciousness2.26 (1.93--2.66)\<0.001Vital signs Low SaO~2~ (age-adjusted)[a](#tbl3fna){ref-type="table-fn"}2.62 (2.29--3.00)\<0.001**Laboratory parameters**WBC count (ref. \<4000 × 10^9^/L) 4000--12 000 × 10^9^/L1.11 (0.91--1.35)0.323 \>12 000 × 10^9^/L1.54 (1.18--2.01)0.002Neutrophil count (ref. ≥1000/μL) \<1000/μL1.77 (1.12--2.79)0.015Neutrophil-to-lymphocyte ratio (ref. \<3.22 (tertile 1)) 3.22--6.33 (tertile 2)1.41 (1.17--1.69)\<0.001 \>6.33 (tertile 3)2.38 (1.99--2.84)\<0.001Platelets (ref. ≥150 000 × 10^9^/L) \<150 000 × 10^9^/L1.41 (1.24--1.60)\<0.001Prolonged APTT (\>39.2 seconds or ratio \>1.25)1.34 (1.09--1.64)0.006INR (ref. ≤1.1) \>1.11.49 (1.28--1.73)\<0.001eGFR (ref. \> 60 mL/min/1.73 m^2^) 30--59 mL/min/1.73 m^2^2.24 (1.95--2.58)\<0.001 \<30 mL/min/1.73 m^2^2.68 (2.21--3.25)\<0.001ALT (ref. \<40 U/L) 40--200 U/L0.84 (0.71--0.99)0.042 \>200 U/L0.86 (0.42--1.78)0.692CRP (ref. ≤5 mg/L) \>5 mg/L2.43 (1.69--3.49)\<0.001[^7][^8]Fig. 2Univariable (A) and multivariable (B) Cox proportional hazards model of variables associated with death. CRP, C-reactive protein; eGFR, estimated glomerular filtration rate; INR, international normalized ratio; N/L, neutrophil-to-lymphocyte ratio; WBC, white blood cell count.Fig. 2Fig. 3Kaplan-Meier plots for death according to age (A) and sex (B).Fig. 3

Discussion {#sec4}
==========

Our cohort describes the presenting characteristics and outcomes of 4035 patients with COVID-19 admitted to 127 centres in Spain during the first month of the country outbreak. We are aware of three prior published nationwide cohorts of hospitalized patients with COVID-19, two from China \[[@bib3],[@bib13]\] and one from the United Kingdom. The majority of patients in all four cohorts were male. However, compared to Chinese patients, those from Spain and the United Kingdom were, on average, two decades older and had a prevalence three times higher of comorbid conditions. It is thus not surprising that mortality was substantially higher in Spain (28%) and the United Kingdom (26%) than in China (1.4% and 3.2%). Presenting features were similar in all cohorts. However, dyspnoea was less frequent in Chinese patients, suggesting a more severe course in the older Spanish and British patients. In our cohort, age was the main determinant of death, as has been in other series of hospitalized patients with COVID-19 \[[@bib3],[@bib8],[@bib9],[@bib14],[@bib19]\].

Independent of the higher prevalence of comorbidities, it cannot be ruled out that older patients could not have been prioritized to receive ICU treatment. Death was also significantly higher in men than in women, as has also been described in other cohorts \[[@bib3],[@bib8],[@bib9],[@bib13],[@bib14]\]. There are sex differences in innate and adaptive immune responses that might have an impact on the inflammatory response and outcomes of COVID-19 and therefore deserve further investigation \[[@bib20]\]. Hypertension was not only the most common comorbidity in our cohort, as in other studies, but it was an independent predictor of mortality. The association between hypertension and poor outcomes in COVID-19 does not seem to be simply a matter of high prevalence; alternative explanations include preexisting hypertensive end-organ or endothelial damage, and interactions between COVID-19 and antihypertensive medications \[[@bib21]\]. Many patients with hypertension were receiving ACE inhibitors or angiotensin II receptor blockers, but these drugs did not increase mortality. Obesity was the fifth most common comorbidity in our cohort, but one with the highest hazard of mortality. Obesity has been found to increase the risk of hospitalization and severe outcomes during influenza seasons \[[@bib22]\]. Recent studies of COVID-19 patients indicate that younger hospitalized individuals are more likely to be obese \[[@bib23]\] and that obesity is associated with severe clinical pictures \[[@bib23], [@bib24], [@bib25]\] and increased mortality \[[@bib14]\]. Other underlying conditions associated with an increased hazard of death were active cancer and cirrhosis, as has been reported elsewhere \[[@bib26],[@bib27]\], meaning that clinicians should consider patients with these underlying conditions to be at high risk for COVID-19 \[[@bib27]\]. We identified several routine laboratory markers as predictors of mortality, including the neutrophil-to-lymphocyte ratio, an indicator of systemic inflammation that has been found to be of prognostic utility in sepsis \[[@bib28]\] and COVID-19 \[[@bib29],[@bib30]\].

Our study is limited by the retrospective design and the high number of sites, which might have jeopardized the quality of the data. We tried to solve this by selecting simple and well-defined variables and by carefully monitoring of the data. Admission criteria might have differed between the sites; nevertheless, we controlled the site effect in the analysis. We could not include in the multivariable model some potentially interesting laboratory parameters; nor could we include changes in laboratory findings over time. The study\'s strengths include the large sample size, which allowed the identification of a high number of predictors of death at admission, the analysis of clinical and laboratory variables, and the inclusion of sites from areas with different incidence rates.

In summary, here we report the clinical characteristics of a large cohort of patients with COVID-19 consecutively admitted to hospitals in Spain during the first month of the epidemic. Our findings provide comprehensive information about the characteristics and complications of severe COVID-19, and may help us identify patients at hospital admission with a higher risk of death.
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**Hospital de Guadarrama**

Caro Bragado, Sarah

Domínguez de Pablos, Gema

**Hospital Universitario de Jaén**

Roldán Fontana, Carolina

Herrero Rodríguez, Carmen

**Hospital de Mataró**

Force Sanmartín, Luis

Aranega, Raquel

**Hospital de Palamós**

Mera Fidalgo, Arantzazu

Toda Savall, María Roca

**Hospital Universitario de Valme**

Merchante Gutiérrez, Nicolas

León Jiménez, Eva María

**Clínica Universitaria de Navarra--Campus Navarra**

Del Pozo León, José Luís

**Hospital Clínica Benidorm**

Serralta Buades, Josefa

Cabrera Tejada, Ginger Giorgiana

**Hospital Doce de Octubre**

Fernández-Ruiz, Mario

Aguado, José María

Maestro de la Calle, Guillermo

**Hospital Universitario Virgen del Rocío**

Cisneros, José Miguel

Pachón, Jerónimo

Aguilar-Guisado, Manuela

Aldabó, Teresa

Avilés, María Dolores

Bueno, Claudio

Cordero-Matía, Elisa

Escoresca, Ana

Gálvez-Benítez, Lydia

Infante, Carmen

Martín, Guillermo

Praena, Julia

Roca, Cristina

Salamanca, Celia

Suárez-Benjumea, Alejandro

**Hospital Universitario Ramón y Cajal**

Vizcarra, Pilar

Quereda, Carmen

Rodriguez Dominguez, Mario José

Gioia, Francesca

Norman, Francesca

Del Campo, Santos

Cantón Moreno, Rafael

**Hospital Universitario San Pedro**

Oteo Revuelta José, Antonio

Santibáñez Sáenz, Paula

Cervera Acedo, Cristina

Ruiz Martínez, Carlos

Blanco Ramos, José R.

Azcona Gutiérrez, José M.

García García, Concepción

Alba Fernández, Jorge

Ibarra Cucalón, Valvanera

San Franco, Mercedes

Metola Sacristán, Luis

**Hospital Quirón A Coruña**

Meijide Míguez, Héctor

Paulos Viñas, Silvia

**HM Sanchinarro**

Menéndez, Justo

Villares Fernández, Paula

Montes Andújar, Lara

**Hospital Francesc de Borja**

Navarro Batet, Álvaro

Ferrer Santolaria, Anna

**Complejo Hospitalario Universitario Nuestra Señora de La Candelaria**

Padilla Salazar, María de la Luz

Abella Vázquez, Lucy

Hayek Peraza, Marcelino

García Pardo, Antonio

Hernández Carballo, Carolina

**Hospital Universitario HM Montepríncipe**

Ruiz Fernández, Andrés Javier

Barrio López, Isabel

**Hospital Universitario HM Puerta del Sur**

Martakoush Alí

**Hospital Universitario HM Torrelodones**

Rojas-Vieyra, Agustín

**Hospital Universitario HM Madrid**

García Calvo, Sonia

Villarreal García-Lomas, Mercedes

**Hospital Don Benito-Villanueva de la Serena**

Vizcaíno Callejón, Marta

García García, María Pilar

**Hospital de Viladecans**

Lérida Urteaga, Ana

Carrasco Fons, Natalia

María Sanjuan, Beatriz

Martín González, Lydia

Sanz Zamudio, Camilo

**Centro Nacional de Epidemiología**

Jarrín, Inmaculada

Alejos, Belén

Moreno, Cristina

Rava, Marta

Iniesta, Carlos

Izquierdo, Rebeca

Suárez-García, Inés

Díaz, Asunción

Ruiz-Alguero, Marta

Hernando, Victoria

Appendix A. Supplementary data {#appsec2}
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The following are the Supplementary data to this article:Multimedia component 1Multimedia component 1 Multimedia component 2Multimedia component 2

Supplementary data to this article can be found online at <https://doi.org/10.1016/j.cmi.2020.07.024>.

[^1]: The first and last author contributed equally to this work.

[^2]: Members of the COVID-19\@Spain Study Group who have made substantial data collection contributions are listed in the [Appendix](#appsec1){ref-type="sec"}.

[^3]: Values are displayed as *n/N* with data (%).

[^4]: eGFR, estimated glomerular filtration rate; IQR, interquartile range.

[^5]: Values are displayed as *n/N* with data (%) unless otherwise indicated.

[^6]: ALT, alanine, aminotransferase; APTT, activated partial thromboplastin time; AST, aspartate aminotransferase; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; COVID-19, coronavirus disease 2019; CRP, C-reactive protein; eGFR, estimated glomerular filtration rate; INR, international normalized ratio; IQR, interquartile range; WBC, white blood cell count.

[^7]: ALT, alanine, aminotransferase; APTT, activated partial thromboplastin time; CI = confidence interval; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; CRP, C-reactive protein; eGFR, estimated glomerular filtration rate; HR = hazard ratio; INR, international normalized ratio; SaO~2~, arterial oxygen saturation; WBC, white blood cell count.

[^8]: Age-adjusted low SaO~2~ ≤90% for patients aged \>50 years and ≤93% for patients aged ≤50 years.
